In Brief: Becton Dickinson
This article was originally published in The Gray Sheet
Executive Summary
Becton Dickinson: Firm signs letter-of-intent to acquire IntelliCode bar coding system from Cincinnati-based electronic medical records firm MedPlus for an upfront payment of $18 mil. and the concurrent purchase of $2 mil. worth of shares in MedPlus common stock. The deal also "provides MedPlus with a five-year royalty arrangement based on future defined net revenues," MedPlus says. Completion of the proposed deal and the purchase of MedPlus stock by BD, which is expected to occur "no later than Jan. 31, 1998," is subject to BD due diligence, approval by the both companies' boards of directors, and regulatory approval...
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.